2.4.1.9 Html 262 329 1 false 96 0 false 7 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://www.sophirisbio.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.sophirisbio.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.sophirisbio.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) false false R4.htm 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.sophirisbio.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations and Comprehensive Loss false false R5.htm 004 - Statement - Consolidated Statements of Shareholders’ Equity (Deficit) Sheet http://www.sophirisbio.com/role/ShareholdersEquityType2or3 Consolidated Statements of Shareholders’ Equity (Deficit) false false R6.htm 005 - Statement - Consolidated Statements of Shareholders’ Equity (Deficit) (Parentheticals) Sheet http://www.sophirisbio.com/role/ShareholdersEquityType2or3_Parentheticals Consolidated Statements of Shareholders’ Equity (Deficit) (Parentheticals) false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.sophirisbio.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows false false R8.htm 007 - Disclosure - Note 1 - Nature of the Business Sheet http://www.sophirisbio.com/role/Note1NatureoftheBusiness Note 1 - Nature of the Business false false R9.htm 008 - Disclosure - Note 2 - Recently Adopted Accounting Pronouncements Sheet http://www.sophirisbio.com/role/Note2RecentlyAdoptedAccountingPronouncements Note 2 - Recently Adopted Accounting Pronouncements false false R10.htm 009 - Disclosure - Note 3 - Summary of Significant Accounting Policies Sheet http://www.sophirisbio.com/role/Note3SummaryofSignificantAccountingPolicies Note 3 - Summary of Significant Accounting Policies false false R11.htm 010 - Disclosure - Note 4 - Net Loss per Common Share Sheet http://www.sophirisbio.com/role/Note4NetLossperCommonShare Note 4 - Net Loss per Common Share false false R12.htm 011 - Disclosure - Note 5 - Securities Available-for-Sale Sheet http://www.sophirisbio.com/role/Note5SecuritiesAvailableforSale Note 5 - Securities Available-for-Sale false false R13.htm 012 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments Sheet http://www.sophirisbio.com/role/Note6FairValueMeasurementandFinancialInstruments Note 6 - Fair Value Measurement and Financial Instruments false false R14.htm 013 - Disclosure - Note 7 - Prepaid Expenses Sheet http://www.sophirisbio.com/role/Note7PrepaidExpenses Note 7 - Prepaid Expenses false false R15.htm 014 - Disclosure - Note 8 - Property and Equipment Sheet http://www.sophirisbio.com/role/Note8PropertyandEquipment Note 8 - Property and Equipment false false R16.htm 015 - Disclosure - Note 9 - Accrued Expenses Sheet http://www.sophirisbio.com/role/Note9AccruedExpenses Note 9 - Accrued Expenses false false R17.htm 016 - Disclosure - Note 10 - Promissory Notes Notes http://www.sophirisbio.com/role/Note10PromissoryNotes Note 10 - Promissory Notes false false R18.htm 017 - Disclosure - Note 11 - Shareholders' equity Sheet http://www.sophirisbio.com/role/Note11Shareholdersequity Note 11 - Shareholders' equity false false R19.htm 018 - Disclosure - Note 12 - Common Share Purchase Warrants Sheet http://www.sophirisbio.com/role/Note12CommonSharePurchaseWarrants Note 12 - Common Share Purchase Warrants false false R20.htm 019 - Disclosure - Note 13 - Stock-based Compensation Plan Sheet http://www.sophirisbio.com/role/Note13StockbasedCompensationPlan Note 13 - Stock-based Compensation Plan false false R21.htm 020 - Disclosure - Note 14 - License Agreements Sheet http://www.sophirisbio.com/role/Note14LicenseAgreements Note 14 - License Agreements false false R22.htm 021 - Disclosure - Note 15 - Income taxes Sheet http://www.sophirisbio.com/role/Note15Incometaxes Note 15 - Income taxes false false R23.htm 022 - Disclosure - Note 16 - Commitments and Contingencies Sheet http://www.sophirisbio.com/role/Note16CommitmentsandContingencies Note 16 - Commitments and Contingencies false false R24.htm 023 - Disclosure - Note 17 - 401(k) Plan Sheet http://www.sophirisbio.com/role/Note17401kPlan Note 17 - 401(k) Plan false false R25.htm 024 - Disclosure - Note 18 - Subsequent Events Sheet http://www.sophirisbio.com/role/Note18SubsequentEvents Note 18 - Subsequent Events false false R26.htm 025 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.sophirisbio.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) false false R27.htm 026 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Tables) Sheet http://www.sophirisbio.com/role/Note3SummaryofSignificantAccountingPoliciesTables Note 3 - Summary of Significant Accounting Policies (Tables) false false R28.htm 027 - Disclosure - Note 4 - Net Loss per Common Share (Tables) Sheet http://www.sophirisbio.com/role/Note4NetLossperCommonShareTables Note 4 - Net Loss per Common Share (Tables) false false R29.htm 028 - Disclosure - Note 5 - Securities Available-for-Sale (Tables) Sheet http://www.sophirisbio.com/role/Note5SecuritiesAvailableforSaleTables Note 5 - Securities Available-for-Sale (Tables) false false R30.htm 029 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Tables) Sheet http://www.sophirisbio.com/role/Note6FairValueMeasurementandFinancialInstrumentsTables Note 6 - Fair Value Measurement and Financial Instruments (Tables) false false R31.htm 030 - Disclosure - Note 7 - Prepaid Expenses (Tables) Sheet http://www.sophirisbio.com/role/Note7PrepaidExpensesTables Note 7 - Prepaid Expenses (Tables) false false R32.htm 031 - Disclosure - Note 8 - Property and Equipment (Tables) Sheet http://www.sophirisbio.com/role/Note8PropertyandEquipmentTables Note 8 - Property and Equipment (Tables) false false R33.htm 032 - Disclosure - Note 9 - Accrued Expenses (Tables) Sheet http://www.sophirisbio.com/role/Note9AccruedExpensesTables Note 9 - Accrued Expenses (Tables) false false R34.htm 033 - Disclosure - Note 10 - Promissory Notes (Tables) Notes http://www.sophirisbio.com/role/Note10PromissoryNotesTables Note 10 - Promissory Notes (Tables) false false R35.htm 034 - Disclosure - Note 11 - Shareholders' equity (Tables) Sheet http://www.sophirisbio.com/role/Note11ShareholdersequityTables Note 11 - Shareholders' equity (Tables) false false R36.htm 035 - Disclosure - Note 12 - Common Share Purchase Warrants (Tables) Sheet http://www.sophirisbio.com/role/Note12CommonSharePurchaseWarrantsTables Note 12 - Common Share Purchase Warrants (Tables) false false R37.htm 036 - Disclosure - Note 13 - Stock-based Compensation Plan (Tables) Sheet http://www.sophirisbio.com/role/Note13StockbasedCompensationPlanTables Note 13 - Stock-based Compensation Plan (Tables) false false R38.htm 037 - Disclosure - Note 14 - License Agreements (Tables) Sheet http://www.sophirisbio.com/role/Note14LicenseAgreementsTables Note 14 - License Agreements (Tables) false false R39.htm 038 - Disclosure - Note 15 - Income taxes (Tables) Sheet http://www.sophirisbio.com/role/Note15IncometaxesTables Note 15 - Income taxes (Tables) false false R40.htm 039 - Disclosure - Note 16 - Commitments and Contingencies (Tables) Sheet http://www.sophirisbio.com/role/Note16CommitmentsandContingenciesTables Note 16 - Commitments and Contingencies (Tables) false false R41.htm 040 - Disclosure - Note 1 - Nature of the Business (Details) Sheet http://www.sophirisbio.com/role/Note1NatureoftheBusinessDetails Note 1 - Nature of the Business (Details) false false R42.htm 041 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details) Sheet http://www.sophirisbio.com/role/Note3SummaryofSignificantAccountingPoliciesDetails Note 3 - Summary of Significant Accounting Policies (Details) false false R43.htm 042 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details) - Property and Equipment, Estimated Useful Lives Sheet http://www.sophirisbio.com/role/PropertyandEquipmentEstimatedUsefulLivesTable Note 3 - Summary of Significant Accounting Policies (Details) - Property and Equipment, Estimated Useful Lives false false R44.htm 043 - Disclosure - Note 4 - Net Loss per Common Share (Details) - Basic and Diluted Net Loss per Share Sheet http://www.sophirisbio.com/role/BasicandDilutedNetLossperShareTable Note 4 - Net Loss per Common Share (Details) - Basic and Diluted Net Loss per Share false false R45.htm 044 - Disclosure - Note 4 - Net Loss per Common Share (Details) - Potentially Dilutive Securities Excluded from Diluted Weighted-average Shares Outstanding Sheet http://www.sophirisbio.com/role/PotentiallyDilutiveSecuritiesExcludedfromDilutedWeightedaverageSharesOutstandingTable Note 4 - Net Loss per Common Share (Details) - Potentially Dilutive Securities Excluded from Diluted Weighted-average Shares Outstanding false false R46.htm 045 - Disclosure - Note 5 - Securities Available-for-Sale (Details) Sheet http://www.sophirisbio.com/role/Note5SecuritiesAvailableforSaleDetails Note 5 - Securities Available-for-Sale (Details) false false R47.htm 046 - Disclosure - Note 5 - Securities Available-for-Sale (Details) - Securities Available-for-Sale Sheet http://www.sophirisbio.com/role/SecuritiesAvailableforSaleTable Note 5 - Securities Available-for-Sale (Details) - Securities Available-for-Sale false false R48.htm 047 - Disclosure - Note 5 - Securities Available-for-Sale (Details) - Amortized Cost and Estimated Fair Value of Securities Sheet http://www.sophirisbio.com/role/AmortizedCostandEstimatedFairValueofSecuritiesTable Note 5 - Securities Available-for-Sale (Details) - Amortized Cost and Estimated Fair Value of Securities false false R49.htm 048 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) Sheet http://www.sophirisbio.com/role/Note6FairValueMeasurementandFinancialInstrumentsDetails Note 6 - Fair Value Measurement and Financial Instruments (Details) false false R50.htm 049 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Assets and Liabilities Measured at Fair Value Measured on a Recurring Basis Sheet http://www.sophirisbio.com/role/AssetsandLiabilitiesMeasuredatFairValueMeasuredonaRecurringBasisTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Assets and Liabilities Measured at Fair Value Measured on a Recurring Basis false false R51.htm 050 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Assumptions, Warrant Liability Sheet http://www.sophirisbio.com/role/FairValueAssumptionsWarrantLiabilityTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Assumptions, Warrant Liability false false R52.htm 051 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Warrant Liability Sheet http://www.sophirisbio.com/role/FairValueReconciliationofWarrantLiabilityTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Warrant Liability false false R53.htm 052 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Assumptions, Stock-based Compensation Liability Sheet http://www.sophirisbio.com/role/FairValueAssumptionsStockbasedCompensationLiabilityTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Assumptions, Stock-based Compensation Liability false false R54.htm 053 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Stock-based Compensation Liability Sheet http://www.sophirisbio.com/role/FairValueReconciliationofStockbasedCompensationLiabilityTable Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Stock-based Compensation Liability false false R55.htm 054 - Disclosure - Note 7 - Prepaid Expenses (Details) Sheet http://www.sophirisbio.com/role/Note7PrepaidExpensesDetails Note 7 - Prepaid Expenses (Details) false false R56.htm 055 - Disclosure - Note 7 - Prepaid Expenses (Details) - Components of Prepaid Expenses Sheet http://www.sophirisbio.com/role/ComponentsofPrepaidExpensesTable Note 7 - Prepaid Expenses (Details) - Components of Prepaid Expenses false false R57.htm 056 - Disclosure - Note 8 - Property and Equipment (Details) Sheet http://www.sophirisbio.com/role/Note8PropertyandEquipmentDetails Note 8 - Property and Equipment (Details) false false R58.htm 057 - Disclosure - Note 8 - Property and Equipment (Details) - Components of Property and Equipment Sheet http://www.sophirisbio.com/role/ComponentsofPropertyandEquipmentTable Note 8 - Property and Equipment (Details) - Components of Property and Equipment false false R59.htm 058 - Disclosure - Note 9 - Accrued Expenses (Details) - Components of Accrued Expenses Sheet http://www.sophirisbio.com/role/ComponentsofAccruedExpensesTable Note 9 - Accrued Expenses (Details) - Components of Accrued Expenses false false R60.htm 059 - Disclosure - Note 10 - Promissory Notes (Details) Notes http://www.sophirisbio.com/role/Note10PromissoryNotesDetails Note 10 - Promissory Notes (Details) false false R61.htm 060 - Disclosure - Note 10 - Promissory Notes (Details) - Future Contractual and Final Fee Payments Notes http://www.sophirisbio.com/role/FutureContractualandFinalFeePaymentsTable Note 10 - Promissory Notes (Details) - Future Contractual and Final Fee Payments false false R62.htm 061 - Disclosure - Note 10 - Promissory Notes (Details) - Actual Interest Expense and Amortization of Debt Discount Notes http://www.sophirisbio.com/role/ActualInterestExpenseandAmortizationofDebtDiscountTable Note 10 - Promissory Notes (Details) - Actual Interest Expense and Amortization of Debt Discount false false R63.htm 062 - Disclosure - Note 11 - Shareholders' equity (Details) Sheet http://www.sophirisbio.com/role/Note11ShareholdersequityDetails Note 11 - Shareholders' equity (Details) false false R64.htm 063 - Disclosure - Note 11 - Shareholders' equity (Details) - Shares Reserved for Future Issuance Sheet http://www.sophirisbio.com/role/SharesReservedforFutureIssuanceTable Note 11 - Shareholders' equity (Details) - Shares Reserved for Future Issuance false false R65.htm 064 - Disclosure - Note 12 - Common Share Purchase Warrants (Details) Sheet http://www.sophirisbio.com/role/Note12CommonSharePurchaseWarrantsDetails Note 12 - Common Share Purchase Warrants (Details) false false R66.htm 065 - Disclosure - Note 12 - Common Share Purchase Warrants (Details) - Common Share Purchase Warrants Activity Sheet http://www.sophirisbio.com/role/CommonSharePurchaseWarrantsActivityTable Note 12 - Common Share Purchase Warrants (Details) - Common Share Purchase Warrants Activity false false R67.htm 066 - Disclosure - Note 13 - Stock-based Compensation Plan (Details) Sheet http://www.sophirisbio.com/role/Note13StockbasedCompensationPlanDetails Note 13 - Stock-based Compensation Plan (Details) false false R68.htm 067 - Disclosure - Note 13 - Stock-based Compensation Plan (Details) - Stock-based Compensation Expense Sheet http://www.sophirisbio.com/role/StockbasedCompensationExpenseTable Note 13 - Stock-based Compensation Plan (Details) - Stock-based Compensation Expense false false R69.htm 068 - Disclosure - Note 13 - Stock-based Compensation Plan (Details) - Fair Value Assumptions of Options Granted Sheet http://www.sophirisbio.com/role/FairValueAssumptionsofOptionsGrantedTable Note 13 - Stock-based Compensation Plan (Details) - Fair Value Assumptions of Options Granted false false R70.htm 069 - Disclosure - Note 13 - Stock-based Compensation Plan (Details) - Stock Option Activity Sheet http://www.sophirisbio.com/role/StockOptionActivityTable Note 13 - Stock-based Compensation Plan (Details) - Stock Option Activity false false R71.htm 070 - Disclosure - Note 14 - License Agreements (Details) Sheet http://www.sophirisbio.com/role/Note14LicenseAgreementsDetails Note 14 - License Agreements (Details) false false R72.htm 071 - Disclosure - Note 14 - License Agreements (Details) - Summary of Remaining Unpaid Milestone Payments by Indication Sheet http://www.sophirisbio.com/role/SummaryofRemainingUnpaidMilestonePaymentsbyIndicationTable Note 14 - License Agreements (Details) - Summary of Remaining Unpaid Milestone Payments by Indication false false R73.htm 072 - Disclosure - Note 15 - Income taxes (Details) Sheet http://www.sophirisbio.com/role/Note15IncometaxesDetails Note 15 - Income taxes (Details) false false R74.htm 073 - Disclosure - Note 15 - Income taxes (Details) - Component of Loss Before Provision for Income Taxes Sheet http://www.sophirisbio.com/role/ComponentofLossBeforeProvisionforIncomeTaxesTable Note 15 - Income taxes (Details) - Component of Loss Before Provision for Income Taxes false false R75.htm 074 - Disclosure - Note 15 - Income taxes (Details) - Components of Provision for Income Taxes from Continuing Operations Sheet http://www.sophirisbio.com/role/ComponentsofProvisionforIncomeTaxesfromContinuingOperationsTable Note 15 - Income taxes (Details) - Components of Provision for Income Taxes from Continuing Operations false false R76.htm 075 - Disclosure - Note 15 - Income taxes (Details) - Reconciliation of Income Taxes to Amount Computed by Applying Statutory Federal Income Tax Rate to Net Loss Sheet http://www.sophirisbio.com/role/ReconciliationofIncomeTaxestoAmountComputedbyApplyingStatutoryFederalIncomeTaxRatetoNetLossTable Note 15 - Income taxes (Details) - Reconciliation of Income Taxes to Amount Computed by Applying Statutory Federal Income Tax Rate to Net Loss false false R77.htm 076 - Disclosure - Note 15 - Income taxes (Details) - Summary of Significant Components of Deferred Tax Assets Sheet http://www.sophirisbio.com/role/SummaryofSignificantComponentsofDeferredTaxAssetsTable Note 15 - Income taxes (Details) - Summary of Significant Components of Deferred Tax Assets false false R78.htm 077 - Disclosure - Note 15 - Income taxes (Details) - Losses Expected to Expire Sheet http://www.sophirisbio.com/role/LossesExpectedtoExpireTable Note 15 - Income taxes (Details) - Losses Expected to Expire false false R79.htm 078 - Disclosure - Note 15 - Income taxes (Details) - Investment Tax Credits and Research and Development Tax Credits Expiration Sheet http://www.sophirisbio.com/role/InvestmentTaxCreditsandResearchandDevelopmentTaxCreditsExpirationTable Note 15 - Income taxes (Details) - Investment Tax Credits and Research and Development Tax Credits Expiration false false R80.htm 079 - Disclosure - Note 16 - Commitments and Contingencies (Details) Sheet http://www.sophirisbio.com/role/Note16CommitmentsandContingenciesDetails Note 16 - Commitments and Contingencies (Details) false false R81.htm 080 - Disclosure - Note 16 - Commitments and Contingencies (Details) - Future Minimum Lease Payments under Non-Cancelable Operating Leases Sheet http://www.sophirisbio.com/role/FutureMinimumLeasePaymentsunderNonCancelableOperatingLeasesTable Note 16 - Commitments and Contingencies (Details) - Future Minimum Lease Payments under Non-Cancelable Operating Leases false false R82.htm 081 - Disclosure - Note 17 - 401(k) Plan (Details) Sheet http://www.sophirisbio.com/role/Note17401kPlanDetails Note 17 - 401(k) Plan (Details) false false R83.htm 082 - Disclosure - Note 18 - Subsequent Events (Details) Sheet http://www.sophirisbio.com/role/Note18SubsequentEventsDetails Note 18 - Subsequent Events (Details) false false All Reports Book All Reports Element sphs_ChangeInFairValueOfStockbasedCompensationLiability had a mix of decimals attribute values: -3 0. Element sphs_IncomeTaxReconciliationForeignWithholdingTaxes had a mix of decimals attribute values: -5 -3. Element us-gaap_CashAndCashEquivalentsAtCarryingValue had a mix of decimals attribute values: -5 -3. Element us-gaap_ClassOfWarrantOrRightOutstanding had a mix of decimals attribute values: -3 0. Element us-gaap_DebtInstrumentFaceAmount had a mix of decimals attribute values: -6 -5. Element us-gaap_DebtInstrumentInterestRateStatedPercentage had a mix of decimals attribute values: 3 5. Element us-gaap_DerivativeGainLossOnDerivativeNet had a mix of decimals attribute values: -5 -3 0. Element us-gaap_DerivativeLiabilitiesNoncurrent had a mix of decimals attribute values: -5 -3 0. Element us-gaap_FairValueAdjustmentOfWarrants had a mix of decimals attribute values: -5 -3. Element us-gaap_ForeignCurrencyTransactionGainLossBeforeTax had a mix of decimals attribute values: -3 0. Element us-gaap_ProceedsFromIssuanceOfDebt had a mix of decimals attribute values: -5 -3. Element us-gaap_ResearchAndDevelopmentExpense had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '001 - Statement - Consolidated Balance Sheets' had a mix of different decimal attribute values. 'Monetary' elements on report '006 - Statement - Consolidated Statements of Cash Flows' had a mix of different decimal attribute values. 'Monetary' elements on report '040 - Disclosure - Note 1 - Nature of the Business (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '053 - Disclosure - Note 6 - Fair Value Measurement and Financial Instruments (Details) - Fair Value Reconciliation of Stock-based Compensation Liability' had a mix of different decimal attribute values. 'Monetary' elements on report '059 - Disclosure - Note 10 - Promissory Notes (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '062 - Disclosure - Note 11 - Shareholders' equity (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '072 - Disclosure - Note 15 - Income taxes (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '079 - Disclosure - Note 16 - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. Process Flow-Through: 001 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 002 - Statement - Consolidated Balance Sheets (Parentheticals) Process Flow-Through: Removing column 'Aug. 23, 2013' Process Flow-Through: 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss Process Flow-Through: 005 - Statement - Consolidated Statements of Shareholders’ Equity (Deficit) (Parentheticals) Process Flow-Through: 006 - Statement - Consolidated Statements of Cash Flows sphs-20141231.xml sphs-20141231.xsd sphs-20141231_cal.xml sphs-20141231_def.xml sphs-20141231_lab.xml sphs-20141231_pre.xml true true